Concord Wealth Partners - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,360
-54.7%
36
-56.1%
0.00%
-100.0%
Q2 2022$3,000
-50.0%
82
-46.4%
0.00%
-50.0%
Q1 2022$6,000
-57.1%
153
-66.2%
0.00%
-33.3%
Q4 2021$14,000
+250.0%
453
+287.2%
0.00%
+50.0%
Q3 2021$4,000
-76.5%
117
-71.9%
0.00%
-60.0%
Q2 2021$17,000
-10.5%
4170.0%0.01%
-16.7%
Q1 2021$19,000
+11.8%
417
+39.0%
0.01%
-53.8%
Q4 2020$17,0003000.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders